Clinical Trial Update: A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily [Phase 1]

View source ↗

Summary

Phase 1 study evaluating vonoprazan concentrations in breast milk of healthy lactating women given 20 mg once daily or 20 mg twice daily; results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease
• Helicobacter Pylori Infection
• Nonerosive Gastroesophageal Reflux Disease

Drugs mentioned

• Vonoprazan (vonoprazan)

Snippet

Sponsor: Phathom Pharmaceuticals, Inc. | Conditions: Erosive Esophagitis, Heartburn | Phase 1 | Status: COMPLETED | Results posted: 2025-03-25